APO Research
Talk to an analyst

APO RESEARCH · REPORT

Veterinary Drug

Veterinary drugs are used to cure and prevent diseases in animals, including animals used for food production. Veterinary drugs are given to animals via feed or drinking water, or by injection.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Veterinary drugs are used to cure and prevent diseases in animals, including animals used for food production. Veterinary drugs are given to animals via feed or drinking water, or by injection.

Selected research

Industry Growth & Trends

Global Veterinary Drug Industry Growth and Trends Forecast to 2032

28 December 2025115 pages

Choose your research edition.

Industry ResearchVeterinary Drug Industry Research Report 2026131 pages · $2,950 USDIndustry Growth & TrendsGlobal Veterinary Drug Industry Growth and Trends Forecast to 2032115 pages · $3,450 USDMarket StructureGlobal Veterinary Drug Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032198 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Veterinary Drug Market Outlook and Growth Opportunities 2026208 pages · $4,250 USDMarket Analysis & ForecastGlobal Veterinary Drug Market Analysis and Forecast 2026-2032209 pages · $4,950 USD

Market perspective

Veterinary drugs are used to cure and prevent diseases in animals, including animals used for food production. Veterinary drugs are given to animals via feed or drinking water, or by injection.

The key players of Veterinary Drug include Zoetis, Elanco, Boehringer Ingelheim, Merck, etc. The top four players of Veterinary Drug account for approximately 56% of the total market. Asia-Pacific is the largest market of Veterinary Drug accounting for about 34%, followed by Europe and North America. In terms of Type, Parasiticides is the largest segment, with a share about 28%. And in terms of Application, the largest application is Pets, followed by Cattle.

Report Scope

Read the full market overview

This report provides a structured, data-driven view of the global Veterinary Drug market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Veterinary Drug market size, estimates, and forecasts are presented in terms of sales volume (M Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Veterinary Drug market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Veterinary Drug.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Veterinary Drug market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Veterinary Drug Market by Company

Zoetis

Elanco

Boehringer Ingelheim

Merck

Virbac

Ceva

Vetoquinol

Dechra

Norbrook

Phibro

Huvepharma

Hipra

Ouro Fino Saude

CAHIC

Orion

Ringpu Biology

Nippon Zenyaku Kogyo

Farmavet-Pasteur

Veterinary Drug Segment by Type

Anti-Infectives

Anti-Inflammatory

Parasiticides

Analgesics

Sedatives

Others

Veterinary Drug Segment by Application

Pets

Cattle

Poultry

Swine

Others

Veterinary Drug Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Veterinary Drug market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Veterinary Drug and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Veterinary Drug.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Veterinary Drug manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Veterinary Drug in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Anti-Infectives Table 2. Major Company of Anti-Inflammatory Table 3. Major Company of Parasiticides Table 4. Major Company of Analgesics Table 5. Major Company of Sedatives Table 6. Major Company of Others Table 7. Global Veterinary Drug Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 8. Global Veterinary Drug Sales by Type (2021-2026) & (M Units) Table 9. Global Veterinary Drug Sales Market Share in Volume by Type (2021-2026) Table 10. Global Veterinary Drug Sales by Type (2021-2026) & (US$ Million) Table 11. Global Veterinary Drug Sales Market Share in Value by Type (2021-2026) Table 12. Global Veterinary Drug Price by Type (2021-2026) & (USD/Unit) Table 13. Global Veterinary Drug Sales by Type (2027-2032) & (M Units) Table 14. Global Veterinary Drug Sales Market Share in Volume by Type (2027-2032) Table 15. Global Veterinary Drug Sales by Type (2027-2032) & (US$ Million) Table 16. Global Veterinary Drug Sales Market Share in Value by Type (2027-2032) Table 17. Global Veterinary Drug Price by Type (2027-2032) & (USD/Unit) Table 18. North America Veterinary Drug Sales by Type (2021-2026) & (M Units) Table 19. North America Veterinary Drug Sales by Type (2021-2026) & (US$ Million) Table 20. Europe Veterinary Drug Sales by Type (2021-2026) & (M Units) Table 21. Europe Veterinary Drug Sales by Type (2021-2026) & (US$ Million) Table 22. Asia-Pacific Veterinary Drug Sales by Type (2021-2026) & (M Units) Table 23. Asia-Pacific Veterinary Drug Sales by Type (2021-2026) & (US$ Million) Table 24. Latin America Veterinary Drug Sales by Type (2021-2026) & (M Units) Table 25. Latin America Veterinary Drug Sales by Type (2021-2026) & (US$ Million) Table 26. Middle East and Africa Veterinary Drug Sales by Type (2021-2026) & (M Units) Table 27. Middle East and Africa Veterinary Drug Sales by Type (2021-2026) & (US$ Million) Table 28. Veterinary Drug Industry Trends Table 29. Veterinary Drug Industry Drivers Table 30. Veterinary Drug Industry Opportunities and Challenges Table 31. Veterinary Drug Industry Restraints Table 32. Global Veterinary Drug Sales Revenue by Company (US$ Million) & (2021-2026) Table 33. Global Veterinary Drug Revenue Market Share by Company (2021-2026) Table 34. Global Veterinary Drug Sales by Company (2021-2026) & (M Units) Table 35. Global Veterinary Drug Sales Share by Company (2021-2026) Table 36. Global Veterinary Drug Market Price by Company (2021-2026) & (USD/Unit) Table 37. Global Veterinary Drug Industry Company Ranking, 2024 VS 2025 VS 2026 Table 38. Global Veterinary Drug Major Company Production Sites and Headquarters Table 39. Global Veterinary Drug Company, Product Type & Application Table 40. Global Veterinary Drug Company Establishment Date Table 41. Global Company Market Concentration Ratio (CR5 and HHI) Table 42. Global Veterinary Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 43. Global Veterinary Drug Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 44. Global Veterinary Drug Sales by Region (2021-2026) & (M Units) Table 45. Global Veterinary Drug Sales Market Share in Volume by Region (2021-2026) Table 46. Global Veterinary Drug Sales by Region (2021-2026) & (US$ Million) Table 47. Global Veterinary Drug Sales Market Share in Value by Region (2021-2026) Table 48. Global Veterinary Drug Sales (M Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 49. Global Veterinary Drug Sales by Region (2027-2032) & (M Units) Table 50. Global Veterinary Drug Sales Market Share in Volume by Region (2027-2032) Table 51. Global Veterinary Drug Sales by Region (2027-2032) & (US$ Million) Table 52. Global Veterinary Drug Sales Market Share in Value by Region (2027-2032) Table 53. Global Veterinary Drug Sales (M Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2027-2032) Table 54. Global Veterinary Drug Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 55. Global Veterinary Drug Sales by Application (2021-2026) & (M Units) Table 56. Global Veterinary Drug Sales Market Share in Volume by Application (2021-2026) Table 57. Global Veterinary Drug Sales by Application (2021-2026) & (US$ Million) Table 58. Global Veterinary Drug Sales Market Share in Value by Application (2021-2026) Table 59. Global Veterinary Drug Price by Application (2021-2026) & (USD/Unit) Table 60. Global Veterinary Drug Sales by Application (2027-2032) & (M Units) Table 61. Global Veterinary Drug Sales Market Share in Volume by Application (2027-2032) Table 62. Global Veterinary Drug Sales by Application (2027-2032) & (US$ Million) Table 63. Global Veterinary Drug Sales Market Share in Value by Application (2027-2032) Table 64. Global Veterinary Drug Price by Application (2027-2032) & (USD/Unit) Table 65. North America Veterinary Drug Sales by Application (2021-2026) & (M Units) Table 66. North America Veterinary Drug Sales by Application (2021-2026) & (US$ Million) Table 67. Europe Veterinary Drug Sales by Application (2021-2026) & (M Units) Table 68. Europe Veterinary Drug Sales by Application (2021-2026) & (US$ Million) Table 69. Asia-Pacific Veterinary Drug Sales by Application (2021-2026) & (M Units) Table 70. Asia-Pacific Veterinary Drug Sales by Application (2021-2026) & (US$ Million) Table 71. Latin America Veterinary Drug Sales by Application (2021-2026) & (M Units) Table 72. Latin America Veterinary Drug Sales by Application (2021-2026) & (US$ Million) Table 73. Middle East and Africa Veterinary Drug Sales by Application (2021-2026) & (M Units) Table 74. Middle East and Africa Veterinary Drug Sales by Application (2021-2026) & (US$ Million) Table 75. Zoetis Company Information Table 76. Zoetis Business Overview Table 77. Zoetis Veterinary Drug Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 78. Zoetis Veterinary Drug Product Portfolio Table 79. Zoetis Recent Development Table 80. Elanco Company Information Table 81. Elanco Business Overview Table 82. Elanco Veterinary Drug Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 83. Elanco Veterinary Drug Product Portfolio Table 84. Elanco Recent Development Table 85. Boehringer Ingelheim Company Information Table 86. Boehringer Ingelheim Business Overview Table 87. Boehringer Ingelheim Veterinary Drug Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 88. Boehringer Ingelheim Veterinary Drug Product Portfolio Table 89. Boehringer Ingelheim Recent Development Table 90. Merck Company Information Table 91. Merck Business Overview Table 92. Merck Veterinary Drug Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 93. Merck Veterinary Drug Product Portfolio Table 94. Merck Recent Development Table 95. Virbac Company Information Table 96. Virbac Business Overview Table 97. Virbac Veterinary Drug Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 98. Virbac Veterinary Drug Product Portfolio Table 99. Virbac Recent Development Table 100. Ceva Company Information Table 101. Ceva Business Overview Table 102. Ceva Veterinary Drug Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 103. Ceva Veterinary Drug Product Portfolio Table 104. Ceva Recent Development Table 105. Vetoquinol Company Information Table 106. Vetoquinol Business Overview Table 107. Vetoquinol Veterinary Drug Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 108. Vetoquinol Veterinary Drug Product Portfolio Table 109. Vetoquinol Recent Development Table 110. Dechra Company Information Table 111. Dechra Business Overview Table 112. Dechra Veterinary Drug Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 113. Dechra Veterinary Drug Product Portfolio Table 114. Dechra Recent Development Table 115. Norbrook Company Information Table 116. Norbrook Business Overview Table 117. Norbrook Veterinary Drug Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 118. Norbrook Veterinary Drug Product Portfolio Table 119. Norbrook Recent Development Table 120. Phibro Company Information Table 121. Phibro Business Overview Table 122. Phibro Veterinary Drug Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 123. Phibro Veterinary Drug Product Portfolio Table 124. Phibro Recent Development Table 125. Huvepharma Company Information Table 126. Huvepharma Business Overview Table 127. Huvepharma Veterinary Drug Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 128. Huvepharma Veterinary Drug Product Portfolio Table 129. Huvepharma Recent Development Table 130. Hipra Company Information Table 131. Hipra Business Overview Table 132. Hipra Veterinary Drug Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 133. Hipra Veterinary Drug Product Portfolio Table 134. Hipra Recent Development Table 135. Ouro Fino Saude Company Information Table 136. Ouro Fino Saude Business Overview Table 137. Ouro Fino Saude Veterinary Drug Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 138. Ouro Fino Saude Veterinary Drug Product Portfolio Table 139. Ouro Fino Saude Recent Development Table 140. CAHIC Company Information Table 141. CAHIC Business Overview Table 142. CAHIC Veterinary Drug Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 143. CAHIC Veterinary Drug Product Portfolio Table 144. CAHIC Recent Development Table 145. Orion Company Information Table 146. Orion Business Overview Table 147. Orion Veterinary Drug Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 148. Orion Veterinary Drug Product Portfolio Table 149. Orion Recent Development Table 150. Ringpu Biology Company Information Table 151. Ringpu Biology Business Overview Table 152. Ringpu Biology Veterinary Drug Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 153. Ringpu Biology Veterinary Drug Product Portfolio Table 154. Ringpu Biology Recent Development Table 155. Nippon Zenyaku Kogyo Company Information Table 156. Nippon Zenyaku Kogyo Business Overview Table 157. Nippon Zenyaku Kogyo Veterinary Drug Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 158. Nippon Zenyaku Kogyo Veterinary Drug Product Portfolio Table 159. Nippon Zenyaku Kogyo Recent Development Table 160. Farmavet-Pasteur Company Information Table 161. Farmavet-Pasteur Business Overview Table 162. Farmavet-Pasteur Veterinary Drug Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 163. Farmavet-Pasteur Veterinary Drug Product Portfolio Table 164. Farmavet-Pasteur Recent Development Table 165. North America Veterinary Drug Market Size Growth Rate (CAGR) by Country (M Units): 2021 VS 2025 VS 2032 Table 166. North America Veterinary Drug Sales by Country (2021-2026) & (M Units) Table 167. North America Veterinary Drug Sales Market Share by Country (2021-2026) Table 168. North America Veterinary Drug Sales Forecast by Country (2027-2032) & (M Units) Table 169. North America Veterinary Drug Sales Market Share Forecast by Country (2027-2032) Table 170. North America Veterinary Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 171. North America Veterinary Drug Market Size by Country (2021-2026) & (US$ Million) Table 172. North America Veterinary Drug Market Share by Country (2021-2026) Table 173. North America Veterinary Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 174. North America Veterinary Drug Market Share Forecast by Country (2027-2032) Table 175. Europe Veterinary Drug Market Size Growth Rate (CAGR) by Country (M Units): 2021 VS 2025 VS 2032 Table 176. Europe Veterinary Drug Sales by Country (2021-2026) & (M Units) Table 177. Europe Veterinary Drug Sales Market Share by Country (2021-2026) Table 178. Europe Veterinary Drug Sales Forecast by Country (2027-2032) & (M Units) Table 179. Europe Veterinary Drug Sales Market Share Forecast by Country (2027-2032) Table 180. Europe Veterinary Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 181. Europe Veterinary Drug Market Size by Country (2021-2026) & (US$ Million) Table 182. Europe Veterinary Drug Market Share by Country (2021-2026) Table 183. Europe Veterinary Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 184. Europe Veterinary Drug Market Share Forecast by Country (2027-2032) Table 185. Asia-Pacific Veterinary Drug Market Size Growth Rate (CAGR) by Country (M Units): 2021 VS 2025 VS 2032 Table 186. Asia-Pacific Veterinary Drug Sales by Country (2021-2026) & (M Units) Table 187. Asia-Pacific Veterinary Drug Sales Market Share by Country (2021-2026) Table 188. Asia-Pacific Veterinary Drug Sales Forecast by Country (2027-2032) & (M Units) Table 189. Asia-Pacific Veterinary Drug Sales Market Share Forecast by Country (2027-2032) Table 190. Asia-Pacific Veterinary Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 191. Asia-Pacific Veterinary Drug Market Size by Country (2021-2026) & (US$ Million) Table 192. Asia-Pacific Veterinary Drug Market Share by Country (2021-2026) Table 193. Asia-Pacific Veterinary Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 194. Asia-Pacific Veterinary Drug Market Share Forecast by Country (2027-2032) Table 195. Latin America Veterinary Drug Market Size Growth Rate (CAGR) by Country (M Units): 2021 VS 2025 VS 2032 Table 196. Latin America Veterinary Drug Sales by Country (2021-2026) & (M Units) Table 197. Latin America Veterinary Drug Sales Market Share by Country (2021-2026) Table 198. Latin America Veterinary Drug Sales Forecast by Country (2027-2032) & (M Units) Table 199. Latin America Veterinary Drug Sales Market Share Forecast by Country (2027-2032) Table 200. Latin America Veterinary Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 201. Latin America Veterinary Drug Market Size by Country (2021-2026) & (US$ Million) Table 202. Latin America Veterinary Drug Market Share by Country (2021-2026) Table 203. Latin America Veterinary Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 204. Latin America Veterinary Drug Market Share Forecast by Country (2027-2032) Table 205. Middle East and Africa Veterinary Drug Market Size Growth Rate (CAGR) by Country (M Units): 2021 VS 2025 VS 2032 Table 206. Middle East and Africa Veterinary Drug Sales by Country (2021-2026) & (M Units) Table 207. Middle East and Africa Veterinary Drug Sales Market Share by Country (2021-2026) Table 208. Middle East and Africa Veterinary Drug Sales Forecast by Country (2027-2032) & (M Units) Table 209. Middle East and Africa Veterinary Drug Sales Market Share Forecast by Country (2027-2032) Table 210. Middle East and Africa Veterinary Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 211. Middle East and Africa Veterinary Drug Market Size by Country (2021-2026) & (US$ Million) Table 212. Middle East and Africa Veterinary Drug Market Share by Country (2021-2026) Table 213. Middle East and Africa Veterinary Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 214. Middle East and Africa Veterinary Drug Market Share Forecast by Country (2027-2032) Table 215. Key Raw Materials Table 216. Raw Materials Key Suppliers Table 217. Veterinary Drug Distributors List Table 218. Veterinary Drug Customers List Table 219. Research Programs/Design for This Report Table 220. Authors List of This Report Table 221. Secondary Sources Table 222. Primary Sources List of Figures Figure 1. Veterinary Drug Image Figure 2. Global Veterinary Drug Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Veterinary Drug Market Size (2021-2032) & (US$ Million) Figure 4. Global Veterinary Drug Sales (2021-2032) & (M Units) Figure 5. Anti-Infectives Image Figure 6. Global Anti-Infectives Sales YoY Growth (2021-2032) & (M Units) Figure 7. Anti-Inflammatory Image Figure 8. Global Anti-Inflammatory Sales YoY Growth (2021-2032) & (M Units) Figure 9. Parasiticides Image Figure 10. Global Parasiticides Sales YoY Growth (2021-2032) & (M Units) Figure 11. Analgesics Image Figure 12. Global Analgesics Sales YoY Growth (2021-2032) & (M Units) Figure 13. Sedatives Image Figure 14. Global Sedatives Sales YoY Growth (2021-2032) & (M Units) Figure 15. Others Image Figure 16. Global Others Sales YoY Growth (2021-2032) & (M Units) Figure 17. Global Veterinary Drug Market Size Overview by Type (2021-2032) & (US$ Million) Figure 18. Global Veterinary Drug Market Share by Type 2025 VS 2032 Figure 19. North America Veterinary Drug Sales Market Share in Volume by Type in 2025 Figure 20. North America Veterinary Drug Sales Market Share in Value by Type in 2025 Figure 21. Europe Veterinary Drug Sales Market Share in Volume by Type in 2025 Figure 22. Europe Veterinary Drug Sales Market Share in Value by Type in 2025 Figure 23. Asia-Pacific Veterinary Drug Sales Market Share in Volume by Type in 2025 Figure 24. Asia-Pacific Veterinary Drug Sales Market Share in Value by Type in 2025 Figure 25. Latin America Veterinary Drug Sales Market Share in Volume by Type in 2025 Figure 26. Latin America Veterinary Drug Sales Market Share in Value by Type in 2025 Figure 27. Middle East and Africa Veterinary Drug Sales Market Share in Volume by Type in 2025 Figure 28. Middle East and Africa Veterinary Drug Sales Market Share in Value by Type in 2025 Figure 29. Global Top 5 and 10 Veterinary Drug Players Market Share by Revenue in 2025 Figure 30. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 31. Pets Image Figure 32. Global Pets Sales YoY Growth (2021-2032) & (M Units) Figure 33. Cattle Image Figure 34. Global Cattle Sales YoY Growth (2021-2032) & (M Units) Figure 35. Poultry Image Figure 36. Global Poultry Sales YoY Growth (2021-2032) & (M Units) Figure 37. Swine Image Figure 38. Global Swine Sales YoY Growth (2021-2032) & (M Units) Figure 39. Others Image Figure 40. Global Others Sales YoY Growth (2021-2032) & (M Units) Figure 41. Global Veterinary Drug Market Size Overview by Application (2021-2032) & (US$ Million) Figure 42. Global Veterinary Drug Market Share by Application 2025 VS 2032 Figure 43. North America Veterinary Drug Sales Market Share in Volume by Application in 2025 Figure 44. North America Veterinary Drug Sales Market Share in Value by Application in 2025 Figure 45. Europe Veterinary Drug Sales Market Share in Volume by Application in 2025 Figure 46. Europe Veterinary Drug Sales Market Share in Value by Application in 2025 Figure 47. Asia-Pacific Veterinary Drug Sales Market Share in Volume by Application in 2025 Figure 48. Asia-Pacific Veterinary Drug Sales Market Share in Value by Application in 2025 Figure 49. Latin America Veterinary Drug Sales Market Share in Volume by Application in 2025 Figure 50. Latin America Veterinary Drug Sales Market Share in Value by Application in 2025 Figure 51. Middle East and Africa Veterinary Drug Sales Market Share in Volume by Application in 2025 Figure 52. Middle East and Africa Veterinary Drug Sales Market Share in Value by Application in 2025 Figure 53. North America Veterinary Drug Sales by Country: 2021 VS 2025 VS 2032 (M Units) Figure 54. North America Veterinary Drug Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. North America Veterinary Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. North America Veterinary Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Europe Veterinary Drug Sales by Country: 2021 VS 2025 VS 2032 (M Units) Figure 58. Europe Veterinary Drug Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Europe Veterinary Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Europe Veterinary Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Asia-Pacific Veterinary Drug Sales by Country: 2021 VS 2025 VS 2032 (M Units) Figure 62. Asia-Pacific Veterinary Drug Sales Share by Country: 2021 VS 2025 VS 2032 Figure 63. Asia-Pacific Veterinary Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 64. Asia-Pacific Veterinary Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 65. Latin America Veterinary Drug Sales by Country: 2021 VS 2025 VS 2032 (M Units) Figure 66. Latin America Veterinary Drug Sales Share by Country: 2021 VS 2025 VS 2032 Figure 67. Latin America Veterinary Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 68. Latin America Veterinary Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 69. Middle East and Africa Veterinary Drug Sales by Country: 2021 VS 2025 VS 2032 (M Units) Figure 70. Middle East and Africa Veterinary Drug Sales Share by Country: 2021 VS 2025 VS 2032 Figure 71. Middle East and Africa Veterinary Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 72. Middle East and Africa Veterinary Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 73. Veterinary Drug Value Chain Figure 74. Key Raw Materials Price Figure 75. Manufacturing Cost Structure Figure 76. Veterinary Drug Production Mode & Process Figure 77. Direct Comparison with Distribution Share Figure 78. Distributors Profiles Figure 79. Years Considered Figure 80. Research Process Figure 81. Key Executives Interviewed

Scope & coverage.

Types
  • Anti-Infectives
  • Anti-Inflammatory
  • Parasiticides
  • Analgesics
  • Sedatives
  • Others
Applications
  • Pets
  • Cattle
  • Poultry
  • Swine
  • Others
Companies covered
  • Zoetis
  • Elanco
  • Boehringer Ingelheim
  • Merck
  • Virbac
  • Ceva
  • Vetoquinol
  • Dechra
  • Norbrook
  • Phibro
  • Huvepharma
  • Hipra
  • Ouro Fino Saude
  • CAHIC
  • Orion
  • Ringpu Biology
  • Nippon Zenyaku Kogyo
  • Farmavet-Pasteur

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Veterinary Drug Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Veterinary Drug Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Veterinary Drug Market by Type
  6. 1.3.1 Anti-Infectives
  7. 1.3.2 Anti-Inflammatory
  8. 1.3.3 Parasiticides
  9. 1.3.4 Analgesics
  10. 1.3.5 Sedatives
  11. 1.3.6 Others
  12. 1.4 Global Veterinary Drug Market Size by Type
  13. 1.4.1 Global Veterinary Drug Market Size Overview by Type (2021-2032)
  14. 1.4.2 Global Veterinary Drug Historic Market Size Review by Type (2021-2026)
  15. 1.4.3 Global Veterinary Drug Forecasted Market Size by Type (2027-2032)
  16. 1.5 Key Regions Market Size by Type
  17. 1.5.1 North America Veterinary Drug Sales Breakdown by Type (2021-2026)
  18. 1.5.2 Europe Veterinary Drug Sales Breakdown by Type (2021-2026)
  19. 1.5.3 Asia-Pacific Veterinary Drug Sales Breakdown by Type (2021-2026)
  20. 1.5.4 South America Veterinary Drug Sales Breakdown by Type (2021-2026)
  21. 1.5.5 Middle East and Africa Veterinary Drug Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Veterinary Drug Industry Trends
  2. 2.2 Veterinary Drug Industry Drivers
  3. 2.3 Veterinary Drug Industry Opportunities and Challenges
  4. 2.4 Veterinary Drug Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Veterinary Drug Revenue (2021-2026)
  2. 3.2 Global Top Players by Veterinary Drug Sales (2021-2026)
  3. 3.3 Global Top Players by Veterinary Drug Price (2021-2026)
  4. 3.4 Global Veterinary Drug Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Veterinary Drug Major Company Production Sites & Headquarters
  6. 3.6 Global Veterinary Drug Company, Product Type & Application
  7. 3.7 Global Veterinary Drug Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Veterinary Drug Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Veterinary Drug Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Veterinary Drug Tier 1, Tier 2, and Tier 3
4 Veterinary Drug Regional Status and Outlook
  1. 4.1 Global Veterinary Drug Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Veterinary Drug Historic Market Size by Region
  3. 4.2.1 Global Veterinary Drug Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Veterinary Drug Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Veterinary Drug Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Veterinary Drug Forecasted Market Size by Region
  7. 4.3.1 Global Veterinary Drug Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Veterinary Drug Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Veterinary Drug Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Veterinary Drug by Application
  1. 5.1 Veterinary Drug Market by Application
  2. 5.1.1 Pets
  3. 5.1.2 Cattle
  4. 5.1.3 Poultry
  5. 5.1.4 Swine
  6. 5.1.5 Others
  7. 5.2 Global Veterinary Drug Market Size by Application
  8. 5.2.1 Global Veterinary Drug Market Size Overview by Application (2021-2032)
  9. 5.2.2 Global Veterinary Drug Historic Market Size Review by Application (2021-2026)
  10. 5.2.3 Global Veterinary Drug Forecasted Market Size by Application (2027-2032)
  11. 5.3 Key Regions Market Size by Application
  12. 5.3.1 North America Veterinary Drug Sales Breakdown by Application (2021-2026)
  13. 5.3.2 Europe Veterinary Drug Sales Breakdown by Application (2021-2026)
  14. 5.3.3 Asia-Pacific Veterinary Drug Sales Breakdown by Application (2021-2026)
  15. 5.3.4 South America Veterinary Drug Sales Breakdown by Application (2021-2026)
  16. 5.3.5 Middle East and Africa Veterinary Drug Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Zoetis
  2. 6.1.1 Zoetis Company Information
  3. 6.1.2 Zoetis Business Overview
  4. 6.1.3 Zoetis Veterinary Drug Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Zoetis Veterinary Drug Product Portfolio
  6. 6.1.5 Zoetis Recent Developments
  7. 6.2 Elanco
  8. 6.2.1 Elanco Company Information
  9. 6.2.2 Elanco Business Overview
  10. 6.2.3 Elanco Veterinary Drug Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Elanco Veterinary Drug Product Portfolio
  12. 6.2.5 Elanco Recent Developments
  13. 6.3 Boehringer Ingelheim
  14. 6.3.1 Boehringer Ingelheim Company Information
  15. 6.3.2 Boehringer Ingelheim Business Overview
  16. 6.3.3 Boehringer Ingelheim Veterinary Drug Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Boehringer Ingelheim Veterinary Drug Product Portfolio
  18. 6.3.5 Boehringer Ingelheim Recent Developments
  19. 6.4 Merck
  20. 6.4.1 Merck Company Information
  21. 6.4.2 Merck Business Overview
  22. 6.4.3 Merck Veterinary Drug Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Merck Veterinary Drug Product Portfolio
  24. 6.4.5 Merck Recent Developments
  25. 6.5 Virbac
  26. 6.5.1 Virbac Company Information
  27. 6.5.2 Virbac Business Overview
  28. 6.5.3 Virbac Veterinary Drug Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Virbac Veterinary Drug Product Portfolio
  30. 6.5.5 Virbac Recent Developments
  31. 6.6 Ceva
  32. 6.6.1 Ceva Company Information
  33. 6.6.2 Ceva Business Overview
  34. 6.6.3 Ceva Veterinary Drug Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Ceva Veterinary Drug Product Portfolio
  36. 6.6.5 Ceva Recent Developments
  37. 6.7 Vetoquinol
  38. 6.7.1 Vetoquinol Company Information
  39. 6.7.2 Vetoquinol Business Overview
  40. 6.7.3 Vetoquinol Veterinary Drug Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Vetoquinol Veterinary Drug Product Portfolio
  42. 6.7.5 Vetoquinol Recent Developments
  43. 6.8 Dechra
  44. 6.8.1 Dechra Company Information
  45. 6.8.2 Dechra Business Overview
  46. 6.8.3 Dechra Veterinary Drug Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Dechra Veterinary Drug Product Portfolio
  48. 6.8.5 Dechra Recent Developments
  49. 6.9 Norbrook
  50. 6.9.1 Norbrook Company Information
  51. 6.9.2 Norbrook Business Overview
  52. 6.9.3 Norbrook Veterinary Drug Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Norbrook Veterinary Drug Product Portfolio
  54. 6.9.5 Norbrook Recent Developments
  55. 6.10 Phibro
  56. 6.10.1 Phibro Company Information
  57. 6.10.2 Phibro Business Overview
  58. 6.10.3 Phibro Veterinary Drug Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Phibro Veterinary Drug Product Portfolio
  60. 6.10.5 Phibro Recent Developments
  61. 6.11 Huvepharma
  62. 6.11.1 Huvepharma Company Information
  63. 6.11.2 Huvepharma Business Overview
  64. 6.11.3 Huvepharma Veterinary Drug Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 Huvepharma Veterinary Drug Product Portfolio
  66. 6.11.5 Huvepharma Recent Developments
  67. 6.12 Hipra
  68. 6.12.1 Hipra Company Information
  69. 6.12.2 Hipra Business Overview
  70. 6.12.3 Hipra Veterinary Drug Sales, Revenue and Gross Margin (2021-2026)
  71. 6.12.4 Hipra Veterinary Drug Product Portfolio
  72. 6.12.5 Hipra Recent Developments
  73. 6.13 Ouro Fino Saude
  74. 6.13.1 Ouro Fino Saude Company Information
  75. 6.13.2 Ouro Fino Saude Business Overview
  76. 6.13.3 Ouro Fino Saude Veterinary Drug Sales, Revenue and Gross Margin (2021-2026)
  77. 6.13.4 Ouro Fino Saude Veterinary Drug Product Portfolio
  78. 6.13.5 Ouro Fino Saude Recent Developments
  79. 6.14 CAHIC
  80. 6.14.1 CAHIC Company Information
  81. 6.14.2 CAHIC Business Overview
  82. 6.14.3 CAHIC Veterinary Drug Sales, Revenue and Gross Margin (2021-2026)
  83. 6.14.4 CAHIC Veterinary Drug Product Portfolio
  84. 6.14.5 CAHIC Recent Developments
  85. 6.15 Orion
  86. 6.15.1 Orion Company Information
  87. 6.15.2 Orion Business Overview
  88. 6.15.3 Orion Veterinary Drug Sales, Revenue and Gross Margin (2021-2026)
  89. 6.15.4 Orion Veterinary Drug Product Portfolio
  90. 6.15.5 Orion Recent Developments
  91. 6.16 Ringpu Biology
  92. 6.16.1 Ringpu Biology Company Information
  93. 6.16.2 Ringpu Biology Business Overview
  94. 6.16.3 Ringpu Biology Veterinary Drug Sales, Revenue and Gross Margin (2021-2026)
  95. 6.16.4 Ringpu Biology Veterinary Drug Product Portfolio
  96. 6.16.5 Ringpu Biology Recent Developments
  97. 6.17 Nippon Zenyaku Kogyo
  98. 6.17.1 Nippon Zenyaku Kogyo Company Information
  99. 6.17.2 Nippon Zenyaku Kogyo Business Overview
  100. 6.17.3 Nippon Zenyaku Kogyo Veterinary Drug Sales, Revenue and Gross Margin (2021-2026)
  101. 6.17.4 Nippon Zenyaku Kogyo Veterinary Drug Product Portfolio
  102. 6.17.5 Nippon Zenyaku Kogyo Recent Developments
  103. 6.18 Farmavet-Pasteur
  104. 6.18.1 Farmavet-Pasteur Company Information
  105. 6.18.2 Farmavet-Pasteur Business Overview
  106. 6.18.3 Farmavet-Pasteur Veterinary Drug Sales, Revenue and Gross Margin (2021-2026)
  107. 6.18.4 Farmavet-Pasteur Veterinary Drug Product Portfolio
  108. 6.18.5 Farmavet-Pasteur Recent Developments
7 North America by Country
  1. 7.1 North America Veterinary Drug Sales by Country
  2. 7.1.1 North America Veterinary Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Veterinary Drug Sales by Country (2021-2026)
  4. 7.1.3 North America Veterinary Drug Sales Forecast by Country (2027-2032)
  5. 7.2 North America Veterinary Drug Market Size by Country
  6. 7.2.1 North America Veterinary Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Veterinary Drug Market Size by Country (2021-2026)
  8. 7.2.3 North America Veterinary Drug Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Veterinary Drug Sales by Country
  2. 8.1.1 Europe Veterinary Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Veterinary Drug Sales by Country (2021-2026)
  4. 8.1.3 Europe Veterinary Drug Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Veterinary Drug Market Size by Country
  6. 8.2.1 Europe Veterinary Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Veterinary Drug Market Size by Country (2021-2026)
  8. 8.2.3 Europe Veterinary Drug Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Veterinary Drug Sales by Country
  2. 9.1.1 Asia-Pacific Veterinary Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Veterinary Drug Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Veterinary Drug Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Veterinary Drug Market Size by Country
  6. 9.2.1 Asia-Pacific Veterinary Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Veterinary Drug Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Veterinary Drug Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Veterinary Drug Sales by Country
  2. 10.1.1 South America Veterinary Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Veterinary Drug Sales by Country (2021-2026)
  4. 10.1.3 South America Veterinary Drug Sales Forecast by Country (2027-2032)
  5. 10.2 South America Veterinary Drug Market Size by Country
  6. 10.2.1 South America Veterinary Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Veterinary Drug Market Size by Country (2021-2026)
  8. 10.2.3 South America Veterinary Drug Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Veterinary Drug Sales by Country
  2. 11.1.1 Middle East and Africa Veterinary Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Veterinary Drug Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Veterinary Drug Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Veterinary Drug Market Size by Country
  6. 11.2.1 Middle East and Africa Veterinary Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Veterinary Drug Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Veterinary Drug Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Veterinary Drug Value Chain Analysis
  2. 12.1.1 Veterinary Drug Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Veterinary Drug Production Mode & Process
  7. 12.2 Veterinary Drug Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Veterinary Drug Distributors
  10. 12.2.3 Veterinary Drug Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst